Arcturus Therapeutics Holdings Inc. (ARCT)

ARCT Revenue

Arcturus Therapeutics Holdings had revenue of $41.67M in the quarter ending September 30, 2024, a decrease of -7.68%. This brings the company's revenue in the last twelve months to $160.40M, down -45.85% year-over-year. In the year 2023, Arcturus Therapeutics Holdings had annual revenue of $166.80M, down -19.03%.

• Revenue (ttm): $160.40M
• Revenue Growth: -45.85%
• P/S Ratio: 2.98
• Revenue / Employee: $891,106
• Employees: 180
• Market Cap: 481.34M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	166.80M	-39.20M	-19.03%
Dec 31, 2022	206.00M	193.64M	1,566.79%
Dec 31, 2021	12.36M	2.82M	29.56%
Dec 31, 2020	9.54M	-11.25M	-54.12%
Dec 31, 2019	20.79M	5.04M	31.97%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.